224 related articles for article (PubMed ID: 15883407)
1. Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update).
Grunfeld E; Dhesy-Thind S; Levine M;
CMAJ; 2005 May; 172(10):1319-20. PubMed ID: 15883407
[No Abstract] [Full Text] [Related]
2. Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-positive breast cancer (summary of the 2001 update). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
Levine M;
CMAJ; 2001 Mar; 164(5):644-6. PubMed ID: 11258212
[No Abstract] [Full Text] [Related]
3. Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients.
J Support Oncol; 2006 Feb; 4(2):66-7. PubMed ID: 16499119
[No Abstract] [Full Text] [Related]
4. Breast cancer and "chemobrain": the consequences of cognitive difficulties following chemotherapy and the potential for recovery.
Reid-Arndt SA
Mo Med; 2009; 106(2):127-31. PubMed ID: 19397112
[TBL] [Abstract][Full Text] [Related]
5. The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients.
Zielinski CC; Awada A; Cameron DA; Cufer T; Martin M; Aapro M
Eur J Cancer; 2008 Feb; 44(3):353-65. PubMed ID: 18191396
[TBL] [Abstract][Full Text] [Related]
6. Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?
Schagen SB; van Dam FS
J Clin Oncol; 2006 Nov; 24(32):5170-1; author reply 5171-2. PubMed ID: 17093282
[No Abstract] [Full Text] [Related]
7. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
8. Cognitive adverse effects of chemotherapy in breast cancer patients.
Correa DD; Ahles TA
Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
[TBL] [Abstract][Full Text] [Related]
9. Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy.
Poppelreuter M; Weis J; Bartsch HH
J Psychosoc Oncol; 2009; 27(2):274-96. PubMed ID: 19337933
[TBL] [Abstract][Full Text] [Related]
10. Managing weight gain after breast cancer.
J Support Oncol; 2006 Feb; 4(2):69-70. PubMed ID: 16499121
[No Abstract] [Full Text] [Related]
11. Cognitive side-effects of adjuvant treatments.
Burstein HJ
Breast; 2007 Dec; 16 Suppl 2():S166-8. PubMed ID: 17719225
[TBL] [Abstract][Full Text] [Related]
12. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
[TBL] [Abstract][Full Text] [Related]
13. Cognitive problems after chemotherapy for breast cancer.
Harv Womens Health Watch; 2002 Oct; 10(2):5-6. PubMed ID: 12393318
[No Abstract] [Full Text] [Related]
14. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
[TBL] [Abstract][Full Text] [Related]
15. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research.
Vardy J; Rourke S; Tannock IF
J Clin Oncol; 2007 Jun; 25(17):2455-63. PubMed ID: 17485710
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
Quesnel C; Savard J; Ivers H
Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
[TBL] [Abstract][Full Text] [Related]
18. Cognitive decline in breast cancer patients.
Health News; 2004 Nov; 10(11):9. PubMed ID: 15655856
[No Abstract] [Full Text] [Related]
19. Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives.
Walker CH; Drew BA; Antoon JW; Kalueff AV; Beckman BS
Cancer Invest; 2012 Feb; 30(2):135-48. PubMed ID: 22250588
[TBL] [Abstract][Full Text] [Related]
20. Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients.
Kayl AE; Meyers CA
Curr Opin Obstet Gynecol; 2006 Feb; 18(1):24-8. PubMed ID: 16493256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
